The human data reflects this advantage, with retatrutide achieving 24.2% weight loss at 48 weeks compared to tirzepatide reaching approximately 21% at 72 weeks in the SURMOUNT trials
The Noom Proactive Health GLP-1 Program monitors 17 key biomarkers that directly impact metabolic function, heart health, inflammation, and hormonal balance
If retatrutide is inadvertently left outside of refrigeration, the consequences depend on several factors: the ambient temperature, the duration of exposure, and whether the product was in its original sealed packaging or already in use
Now, they hold FDA approval for helping individuals manage their weight
Theres no clinical evidence that commercial GLP-1 patches produce any meaningful weight loss
If you experience any unusual reactions, we recommend discontinuing use and consulting your healthcare provider promptly